Key result
Trehalose significantly abates myocardial hypertrophy and pressure overload-induced cardiomyocyte apoptosis in mice, partly by promoting autophagic degradation of GATA4.
Why the study?
The study was conducted to probe the effect of trehalose on myocardial hypertrophy and determine its specific molecular mechanism.
Does trehalose improve myocardial hypertrophy and cardiac function in a mouse model of pressure overload?
Does trehalose improve myocardial hypertrophy and cardiac function in a mouse model of pressure overload?
Trehalose exerts cardioprotective effects against pressure overload-induced myocardial hypertrophy and apoptosis by promoting autophagic degradation of GATA4.
Answers are grounded in this paper and cite their sources.
Trehalose effects in murine TAC remain preliminary; leaves open any role in human hypertrophy.
OBJECTIVE: To probe the effect of trehalose on myocardial hypertrophy and its specific molecular mechanism. METHODS: C57BL/6J male mice were divided into four subgroups: Sham operation subgroup (Sham), negative sham subgroup (Sham+Trehalose), transverse aortic constriction (TAC), and trehalose treatment subgroup (TAC+Trehalose). Immediately after the TAC operation, trehalose at a dose of 10 mg/kg was given daily via gavage. After four weeks, changes in cardiac function were evaluated using ultrasound to measure EF (ejection fraction), FS (fractional shortening), IVRT (isovolumic relaxation time), MPI (myocardial performance index), Tau (isovolumic relaxation time constant), LVESP (left ventricular end-systolic pressure), and EDPVR (end-diastolic pressure-volume relationship). The profiles of autophagy-associated proteins (p62, LC3II/I, and Beclin-1) and GATA4 protein in mice myocardial tissues were assessed by Western blotting (WB). Myocardial cells were classified from TAC mice into five groups: Control, Trehalose, Phenylephrine (PE), PE+Trehalose, and PE+Trehalose+autophagy inhibitor chloroquine groups. In the PE group, cardiomyocytes were treated with 50 μmol/L PE. Then, the cells were treated with trehalose (100 μmol/L), trehalose (100 μmol/L)+autophagy (20 μmol/L) for 24 hours respectively. The Control group was treated with the same amount of normal saline. Flow cytometry was utilized to detect myocardial cell apoptosis in each subgroup. The alterations in apoptosis and autophagy-correlated proteins (p62, LC3II/I, and Beclin-1) were assessed by WB. Additionally, the level of GATA4 protein upstream of autophagy was estimated. Furthermore, the expression levels of pro-apoptotic proteins Bad, BAX, Cleaved-caspase-3, and anti-apoptotic protein Bcl-2 were examined by WB. At the cellular level, trehalose significantly decreased PE-elicited apoptosis and promoted the protein expressions of Beclin-1 and LC3 II/I in cardiomyocytes while significantly dampening the profiles of p62 and GATA4 in cells. The effect of trehalose and chloroquine treatment was significantly greater than that of the trehalose group. CONCLUSIONS: Trehalose significantly abates myocardial hypertrophy and pressure overload-induced cardiomyocyte apoptosis in mice. The cardioprotective effect of trehalose on enhanced autophagy is attributed, at least in part, to the promotion of autophagic degradation of GATA4.
No takes yet. Share an insight, caveat, or question.
Chai et al. (2023) studied Myocardial hypertrophy. Trehalose vs. Sham, TAC alone, or normal saline/PE alone was evaluated on Myocardial hypertrophy, cardiac function, and cardiomyocyte apoptosis (p=< 0.05). Trehalose significantly abates myocardial hypertrophy and pressure overload-induced cardiomyocyte apoptosis in mice, partly by promoting autophagic degradation of GATA4.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: